BioAffinity Technologies (NASDAQ:BIAFW) Stock Price Down 7.6%
BioAffinity Technologies (NASDAQ:BIAFW) Stock Price Down 7.6%
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level.bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) shares fell 7.6% on Tuesday . The stock traded as low as $0.35 and last traded at $0.49. 9,877 shares changed hands during trading, a decline of 70% from the average session volume of 33,233 shares. The stock had previously closed at $0.53.
生物亲和技术公司(纳斯达克代码：BIAFW-GET Rating)股价周二下跌7.6%。该股交易价格低至0.35美元，最后报0.49美元。9,877股股票在交易中易手，较33,233股的平均成交量下降了70%。该股此前收盘价为0.53美元。
bioAffinity Technologies Trading Down 7.6 %
生物亲和力技术公司股价下跌7.6%
The firm has a 50-day simple moving average of $0.43.
该公司的50日简单移动均线为0.43美元。
Institutional Investors Weigh In On bioAffinity Technologies
机构投资者看好生物亲和技术
An institutional investor recently bought a new position in bioAffinity Technologies stock. Armistice Capital LLC acquired a new stake in bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 204,082 shares of the company's stock, valued at approximately $72,000.
一家机构投资者最近买入了BioAffity Technologies股票的新头寸。根据美国证券交易委员会的最新披露，停战资本有限责任公司在第三季度收购了生物亲和技术公司(BIAFW-GET Rating)的新股份。该公司收购了204,082股该公司的股票，价值约72,000美元。
About bioAffinity Technologies
关于生物亲和技术
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level.
生物亲和技术公司是一家生物技术公司，致力于开发非侵入性诊断测试和靶向癌症疗法。该公司提供CyPath肺部诊断测试，用于早期发现肺癌。它还研究在细胞水平上治疗癌症的靶向疗法。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on bioAffinity Technologies (BIAFW)
- Will Nordstrom Stock be the Grinch This Year?
- Harpoon Therapeutics Remains Volatile After Promising News
- We Are the Champions: 3 Dividend Growers Wall Street Loves
- What is Market Structure in Trading?
- Institutional Selling Is No Headwind For Nike
- 免费获取StockNews.com关于生物亲和技术的研究报告(BIAFW)
- 诺德斯特龙股票公司会成为今年的格林奇吗？
- 鱼叉治疗公司在有希望的消息传出后仍不稳定
- 我们是冠军：华尔街钟爱的3位股息种植者
- 交易中的市场结构是什么？
- 机构销售对耐克来说不是逆风
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
接受《生物亲和技术日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯，接收最新新闻和分析师对BioAffity Technologies及相关公司的评级的每日摘要。